Deploy stronger authentication
Applied rSecureKey MFA across 55 protected accounts.
Request a demo →
A biotechnology company secured research access, addressed the identity-control clauses in its 21 CFR Part 11 gap assessment and turned access evidence into a prepared answer for auditors, partners and investors.
The company had scientific value to protect but lacked an access-control model it could confidently present to regulators, prospective partners or investors. Regulated systems had Part 11 identity gaps, shared functions relied on shared credentials, administrative rights remained standing, and access activity was not producing usable evidence.
Rainbow Secure deployed rSecureKey MFA across 55 accounts, established role-scoped IAM and recurring access review, brought 11 privileged accounts under PAM, converted 8 shared team accounts to named Team Access and exported authentication and access activity to the company’s existing Microsoft Sentinel environment.
The engagement connected identity security to three business-critical reviews: regulatory inspection, partner vendor-security assessment and investor technical diligence. It also drew a clear line between the identity clauses addressed by Rainbow Secure and the validation, signature and record controls that remained with the company.
Applied rSecureKey MFA across 55 protected accounts.
Established IAM entitlements and recurring review instead of accumulated access.
Moved 11 accounts from standing privilege to controlled PAM.
Converted 8 team accounts to individually authenticated Team Access.
Exported authentication and access evidence to Microsoft Sentinel.
Documented which identity clauses were addressed and which controls remained with validated systems and SOPs.
A dataset that leaves cannot be recovered or made secret again.
Loss could give a competitor a head start funded by the company’s research.
Disclosure can affect commercial advantage and patentability.
Weak identity controls can create data-integrity findings and remediation work.
Security-review findings can delay collaboration, diligence and financing.
The client audit passed and the 21 CFR Part 11 gap assessment was signed off with the identity-control clauses addressed and the remaining system and procedural scope clearly assigned. Fifty-five accounts received multidimensional MFA, eight shared logins became named Team Access, eleven privileged accounts came under PAM and access evidence became searchable in Microsoft Sentinel.
Verified results from the supplied Biotechnology Company case study. Rainbow Secure addressed identity-related controls; system validation, in-application audit trails, electronic-signature controls and certification remain the company’s responsibility.We can map the users, applications, access risks and evidence requirements involved in your first use case.
Discuss your use case →